Cargando…
Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder.
Expression of the p53, the epidermal growth factor receptor (EGFr; c-erbB-1) and c-erbB-2 proteins was studied in 82 patients with primary transitional cell carcinoma of the bladder using an immuno-histochemical method. Strong or moderate staining was found in 18% of tumours for p53 with weaker stai...
Autores principales: | Wright, C., Mellon, K., Johnston, P., Lane, D. P., Harris, A. L., Horne, C. H., Neal, D. E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1991
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1972558/ https://www.ncbi.nlm.nih.gov/pubmed/1712624 |
Ejemplares similares
-
Expression of c-erbB-2 protein product in bladder cancer.
por: Wright, C., et al.
Publicado: (1990) -
Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladder.
por: Coombs, L. M., et al.
Publicado: (1991) -
ErbB2 inhibition by lapatinib promotes degradation of mutant p53 protein in cancer cells
por: Li, Dun, et al.
Publicado: (2016) -
Expression and activation of erbB-2 and epidermal growth factor receptor in lung adenocarcinomas.
por: Rachwal, W. J., et al.
Publicado: (1995) -
Overexpression of mutant p53 and c-erbB-2 proteins and breast tumour take in mice.
por: Mehta, R. R., et al.
Publicado: (1995)